Cadila Healthcare edges up on plans of developing vaccines for ‘Congo Virus’ and ‘Ebola Virus’

31 Dec 2014 Evaluate

Cadila Healthcare is currently trading at Rs. 1573.00, up by 4.35 points or 0.28 % from its previous closing of Rs. 1568.65 on the BSE.

The scrip opened at Rs. 1560.00 and has touched a high and low of Rs. 1583.00 and Rs. 1556.50 respectively. So far 1416 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1760.00 on 11-Nov-2014 and a 52 week low of Rs. 730.25 on 06-Jan-2014.

Last one week high and low of the scrip stood at Rs. 1617.90 and Rs. 1520.45 respectively. The current market cap of the company is Rs. 32237.65 crore.

The promoters holding in the company stood at 74.79 % while Institutions and Non-Institutions held 14.51 % and 10.69 % respectively.

Cadila Healthcare is developing vaccines for ‘Congo Virus’ and ‘Ebola Virus’ as a part of Company's vaccine development programme. However, the company has not shared investment details.

Cadila Healthcare operates in areas of active pharmaceutical ingredients (API) to formulations, and animal health products to cosmeceuticals.

Zydus Lifesciences Share Price

983.05 15.25 (1.58%)
10-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1505.20
Dr. Reddys Lab 5922.45
Cipla 1339.45
Zydus Lifesciences 983.05
Lupin 1609.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.